Secretion of bladder tumor-derived hyaluronidase activity by invasive bladder tumor cells

Cancer Letters

Volumn 131, Issue 1, 1998, Pages 21-27

  Lokeshwar, Vinata B ^a   Soloway, Mark S ^a   Block, Norman L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Bladder cancer marker; Hyaluronic acid; Hyaluronidase; Tumor angiogenesis

Indexed keywords

GLYCOSAMINOGLYCAN; HYALURONIC ACID; HYALURONIDASE;

ADULT; AGED; ANGIOGENESIS; BLADDER EPITHELIUM; BLADDER TUMOR; CANCER GRADING; CANCER INVASION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL;

ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYALURONOGLUCOSAMINIDASE; MIDDLE AGED; NEOPLASM INVASIVENESS; TISSUE EXTRACTS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0032508712     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00197-9     Document Type: Conference Paper

References (23)

1. Stetler-Stevenson W.G., Aznavoorian S., Liotta L.A. Tumor cell interactions with extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9:1993;541-573.
2. McCormick B.A., Zeller B.R. Adhesive interactions in angiogenesis and metastasis. Pharmacol. Ther. 53:1992;239-260.
3. Folkman J. The role of angiogenesis in tumor growth. Semin. Cancer Biol. 3:1992;65-71.
4. Laurent T.C., Fraser R.E. Hyaluronan. FASEB J. 6:1992;2397-2404.
5. W. Knudson, C. Biswas, X.-Q. Li, R.E. Nemec, B.P. Toole, The role and regulation of tumor associated hyaluronan, in: J. Whelan (Ed.), The Biology of Hyaluronan, Ciba Foundation Symposium 143, Wiley, Chichester, NY, 1989, pp. 150-169.
6. Thomas L., Etoh T., Stamenkovic S., Mihm M.C., Byers H.P. Migration of human melanoma cells on hyaluronate is related to CD44 expression. J. Invest. Dermatol. 100:1993;115-120.
7. Hobarth K., Maier U., Marberger M. Topical chemoprophylaxis of superficial bladder cancer by mitomycin C and hyaluronidase. Eur. Urol. 21:1992;206-210.
8. West D.C., Kumar S. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp. Cell Res. 183:1989;179-196.
9. Lokeshwar V.B., Öbek C., Soloway M.S., Block N.L. Tumor-associated hyaluronic acid: a sensitive and specific urine marker for bladder cancer. Cancer Res. 57:1997;773-777.
10. Pham H.T., Block N.L., Lokeshwar V.B. Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer. Cancer Res. 57:1997;778-783.
11. Heney N.M. Natural history of bladder cancer. Urol. Clin. North Am. 19:1992;429-435.
12. Dinney C.P.N., Fishback R., Singh R.K., Eve B., Pathak S., Brown N., Xie B., Fan D., Bucana C.D., Fidler I.J., Killion J.J. Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. J. Urol. 154:1995;1532-1538.
13. Soloway M.S. The management of superficial bladder cancer. Cancer. 45:1980;1856-1865.
14. Lokeshwar V.B., Lokeshwar B.L., Pham H.T., Block N.L. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res. 56:1996;651-657.
15. Frost G.I., Csoka T.B., Wong T., Stern R. Purification, cloning and expression of human plasma hyaluronidase. Biophys. Biochem. Res. Commun. 236:1997;10-15.
16. Gamchl M., Sagan S., Ketter S., Kreil G. The human sperm protein PH-20 has hyaluronidase activity. FEBS Lett. 336:1993;545-548.
17. Maier U., Baumgartner G. Metaphylactic effect of mitomycin C without hyaluronidase after transurethral resection of bladder cancer: randomized trial. J. Urol. 141:1989;529-530.
18. Baumgartner G., Neumann H. Hyaluronidase in cytostatic therapy of ENT tumors. Laryngol. Rhinol. Otol. 66:1987;195-199.
19. Baumgartner G. Hyaluronidase in therapy of malignant diseases. Wien Klin. Wochenschr. 174(Suppl.):1987;1-22.
20. Maier U., Baumgartner G. Mitomycin C plasma levels after intravesical instillation with and without hyaluronidase. J. Urol. 135:1986;845-846.
21. Schumer J., Klocker J., Tidstrand J., Rab B., Allmayer H. Cisplatin, vindesine and hyaluronidase combined with simultaneous radiotherapy of advanced head and neck tumors. Oncologie. 47:1990;310-312.
22. Becker K., Bannke S., Spruss T., Bernhardt G., Schonenberg H., Scheis W. Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo. J. Cancer Res. Clin. Oncol. 118(8):1992;591-596.
23. Lokeshwar V.B., Iida N., Bourguignon L.Y.W. Endothelial cell adhesion molecule GP116 is a new CD44 variant (Ex14-v10) involved in mediating hyaluronic acid-induced functions. J. Biol. Chem. 271:1996;23853-23864.